Abbott Laboratories buy Stifel Nicolaus
Start price
17.04.25
/
50%
€115.06
Target price
17.04.26
€127.60
Performance (%)
-28.49%
Price
17.04.26
€82.28
This prediction will end soon
Summary
This prediction is currently active. The prediction for Abbott Laboratories disappoints with a performance of -28.49%. This prediction currently runs until 17.04.26. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Abbott Laboratories | -3.766% | -3.766% | -28.576% |
| iShares Core DAX® | 0.789% | 1.975% | |
| iShares Nasdaq 100 | 4.226% | 4.344% | |
| iShares Nikkei 225® | 3.285% | 6.991% | |
| iShares S&P 500 | 2.496% | 2.759% |
Comments by Stifel_Nicolaus for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Stifel Nicolaus from $135.00 to $145.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Stifel_Nicolaus for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€81.24
17.04.26
17.04.26
€101.90
17.04.27
17.04.27
1.28%
17.04.26
17.04.26
Abbott Laboratories
Start price
Target price
Perf. (%)
€113.50
23.01.25
23.01.25
€129.61
23.01.26
23.01.26
-19.76%
24.01.26
24.01.26